191 related articles for article (PubMed ID: 24092501)
41. Sulforaphane suppresses the viability and metastasis, and promotes the apoptosis of bladder cancer cells by inhibiting the expression of FAT‑1.
Wang F; Liu P; An H; Zhang Y
Int J Mol Med; 2020 Sep; 46(3):1085-1095. PubMed ID: 32705150
[TBL] [Abstract][Full Text] [Related]
42. Sulforaphane Inhibits Adhesion and Migration of Cisplatin- and Gemcitabine-Resistant Bladder Cancer Cells In Vitro.
Xie H; Rutz J; Maxeiner S; Grein T; Thomas A; Juengel E; Chun FK; Cinatl J; Haferkamp A; Tsaur I; Blaheta RA
Nutrients; 2024 Feb; 16(5):. PubMed ID: 38474751
[TBL] [Abstract][Full Text] [Related]
43. Sulforaphane inhibits invasion by phosphorylating ERK1/2 to regulate E-cadherin and CD44v6 in human prostate cancer DU145 cells.
Peng X; Zhou Y; Tian H; Yang G; Li C; Geng Y; Wu S; Wu W
Oncol Rep; 2015 Sep; 34(3):1565-72. PubMed ID: 26134113
[TBL] [Abstract][Full Text] [Related]
44. Notch activation by phenethyl isothiocyanate attenuates its inhibitory effect on prostate cancer cell migration.
Kim SH; Sehrawat A; Sakao K; Hahm ER; Singh SV
PLoS One; 2011; 6(10):e26615. PubMed ID: 22039516
[TBL] [Abstract][Full Text] [Related]
45. Hydrogen sulfide mediates the anti-survival effect of sulforaphane on human prostate cancer cells.
Pei Y; Wu B; Cao Q; Wu L; Yang G
Toxicol Appl Pharmacol; 2011 Dec; 257(3):420-8. PubMed ID: 22005276
[TBL] [Abstract][Full Text] [Related]
46. Sulforaphane-induced apoptosis involves the type 1 IP3 receptor.
Hudecova S; Markova J; Simko V; Csaderova L; Stracina T; Sirova M; Fojtu M; Svastova E; Gronesova P; Pastorek M; Novakova M; Cholujova D; Kopacek J; Pastorekova S; Sedlak J; Krizanova O
Oncotarget; 2016 Sep; 7(38):61403-61418. PubMed ID: 27528021
[TBL] [Abstract][Full Text] [Related]
47. Knock-down of plasminogen-activator inhibitor-1 enhances expression of E-cadherin and promotes epithelial differentiation of human pancreatic adenocarcinoma cells.
Lupu-Meiri M; Geras-Raaka E; Lupu R; Shapira H; Sandbank J; Segal L; Gershengorn MC; Oron Y
J Cell Physiol; 2012 Nov; 227(11):3621-8. PubMed ID: 22331587
[TBL] [Abstract][Full Text] [Related]
48. ERK and JNK signaling pathways are involved in the regulation of activator protein 1 and cell death elicited by three isothiocyanates in human prostate cancer PC-3 cells.
Xu C; Shen G; Yuan X; Kim JH; Gopalkrishnan A; Keum YS; Nair S; Kong AN
Carcinogenesis; 2006 Mar; 27(3):437-45. PubMed ID: 16272172
[TBL] [Abstract][Full Text] [Related]
49. Regulation of Nrf2- and AP-1-mediated gene expression by epigallocatechin-3-gallate and sulforaphane in prostate of Nrf2-knockout or C57BL/6J mice and PC-3 AP-1 human prostate cancer cells.
Nair S; Barve A; Khor TO; Shen GX; Lin W; Chan JY; Cai L; Kong AN
Acta Pharmacol Sin; 2010 Sep; 31(9):1223-40. PubMed ID: 20729872
[TBL] [Abstract][Full Text] [Related]
50. Sulforaphane increases the efficacy of anti-androgens by rapidly decreasing androgen receptor levels in prostate cancer cells.
Khurana N; Talwar S; Chandra PK; Sharma P; Abdel-Mageed AB; Mondal D; Sikka SC
Int J Oncol; 2016 Oct; 49(4):1609-19. PubMed ID: 27499349
[TBL] [Abstract][Full Text] [Related]
51. Phenethyl isothiocyanate suppresses inhibitor of apoptosis family protein expression in prostate cancer cells in culture and in vivo.
Sakao K; Desineni S; Hahm ER; Singh SV
Prostate; 2012 Jul; 72(10):1104-16. PubMed ID: 22161756
[TBL] [Abstract][Full Text] [Related]
52. The chemopreventive isothiocyanate sulforaphane reduces anoikis resistance and anchorage-independent growth in non-small cell human lung cancer cells.
Tsai JY; Tsai SH; Wu CC
Toxicol Appl Pharmacol; 2019 Jan; 362():116-124. PubMed ID: 30365975
[TBL] [Abstract][Full Text] [Related]
53. Down-regulation of E-cadherin enhances prostate cancer chemoresistance via Notch signaling.
Wang W; Wang L; Mizokami A; Shi J; Zou C; Dai J; Keller ET; Lu Y; Zhang J
Chin J Cancer; 2017 Mar; 36(1):35. PubMed ID: 28356132
[TBL] [Abstract][Full Text] [Related]
54. Survivin gene silencing sensitizes prostate cancer cells to selenium growth inhibition.
Liu X; Gao R; Dong Y; Gao L; Zhao Y; Zhao L; Zhao X; Zhang H
BMC Cancer; 2010 Aug; 10():418. PubMed ID: 20698994
[TBL] [Abstract][Full Text] [Related]
55. Aspirin Inhibits IKK-β-mediated Prostate Cancer Cell Invasion by Targeting Matrix Metalloproteinase-9 and Urokinase-Type Plasminogen Activator.
Shi C; Zhang N; Feng Y; Cao J; Chen X; Liu B
Cell Physiol Biochem; 2017; 41(4):1313-1324. PubMed ID: 28278500
[TBL] [Abstract][Full Text] [Related]
56. Sulforaphane Reduces Prostate Cancer Cell Growth and Proliferation In Vitro by Modulating the Cdk-Cyclin Axis and Expression of the CD44 Variants 4, 5, and 7.
Rutz J; Thaler S; Maxeiner S; Chun FK; Blaheta RA
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33218199
[TBL] [Abstract][Full Text] [Related]
57. Inhibition of plasminogen activator inhibitor-1 is a potential therapeutic strategy in ovarian cancer.
Mashiko S; Kitatani K; Toyoshima M; Ichimura A; Dan T; Usui T; Ishibashi M; Shigeta S; Nagase S; Miyata T; Yaegashi N
Cancer Biol Ther; 2015; 16(2):253-60. PubMed ID: 25587663
[TBL] [Abstract][Full Text] [Related]
58. CX3CL1 increases invasiveness and metastasis by promoting epithelial-to-mesenchymal transition through the TACE/TGF-α/EGFR pathway in hypoxic androgen-independent prostate cancer cells.
Tang J; Xiao L; Cui R; Li D; Zheng X; Zhu L; Sun H; Pan Y; Du Y; Yu X
Oncol Rep; 2016 Feb; 35(2):1153-62. PubMed ID: 26718770
[TBL] [Abstract][Full Text] [Related]
59. Atg5 regulates phenethyl isothiocyanate-induced autophagic and apoptotic cell death in human prostate cancer cells.
Bommareddy A; Hahm ER; Xiao D; Powolny AA; Fisher AL; Jiang Y; Singh SV
Cancer Res; 2009 Apr; 69(8):3704-12. PubMed ID: 19336571
[TBL] [Abstract][Full Text] [Related]
60. Suppression of FOXQ1 in benzyl isothiocyanate-mediated inhibition of epithelial-mesenchymal transition in human breast cancer cells.
Sehrawat A; Kim SH; Vogt A; Singh SV
Carcinogenesis; 2013 Apr; 34(4):864-73. PubMed ID: 23276794
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]